Huili Lu

1.4k total citations
65 papers, 1.0k citations indexed

About

Huili Lu is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Huili Lu has authored 65 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 24 papers in Oncology and 23 papers in Immunology. Recurrent topics in Huili Lu's work include Monoclonal and Polyclonal Antibodies Research (17 papers), Immune Cell Function and Interaction (10 papers) and Immunotherapy and Immune Responses (8 papers). Huili Lu is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (17 papers), Immune Cell Function and Interaction (10 papers) and Immunotherapy and Immune Responses (8 papers). Huili Lu collaborates with scholars based in China, United States and Germany. Huili Lu's co-authors include Jianwei Zhu, Yueqing Xie, Mingyuan Wu, Wei Han, Shunying Zhu, Ziyan Wang, Y. Yu, Yuhong Xu, Di Xiang and Baohong Zhang and has published in prestigious journals such as Blood, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Huili Lu

63 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huili Lu China 20 481 316 242 222 103 65 1.0k
Arvinder Kapur United States 20 862 1.8× 333 1.1× 531 2.2× 120 0.5× 82 0.8× 39 1.6k
Zahra Payandeh Iran 22 696 1.4× 262 0.8× 268 1.1× 145 0.7× 56 0.5× 56 1.2k
Kevin Van der Jeught Belgium 16 700 1.5× 536 1.7× 489 2.0× 104 0.5× 97 0.9× 23 1.3k
Haixun Guo United States 25 1.0k 2.2× 390 1.2× 431 1.8× 521 2.3× 71 0.7× 41 1.9k
Ana Sofía Carvalho Portugal 19 987 2.1× 154 0.5× 339 1.4× 105 0.5× 53 0.5× 69 1.4k
Masaru Koyama Japan 6 530 1.1× 215 0.7× 334 1.4× 121 0.5× 65 0.6× 8 1.3k
Jung‐Tung Hung Taiwan 21 812 1.7× 256 0.8× 639 2.6× 140 0.6× 77 0.7× 47 1.5k
Ursula Elsässer‐Beile Germany 21 434 0.9× 422 1.3× 558 2.3× 433 2.0× 74 0.7× 53 1.4k
Latha Pathangey United States 16 483 1.0× 323 1.0× 444 1.8× 169 0.8× 151 1.5× 26 1.1k

Countries citing papers authored by Huili Lu

Since Specialization
Citations

This map shows the geographic impact of Huili Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huili Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huili Lu more than expected).

Fields of papers citing papers by Huili Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huili Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huili Lu. The network helps show where Huili Lu may publish in the future.

Co-authorship network of co-authors of Huili Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Huili Lu. A scholar is included among the top collaborators of Huili Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huili Lu. Huili Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Wei, Luyao Song, Ying Qin, et al.. (2024). A tumor-conditional IL-15 safely synergizes with immunotherapy to enhance antitumor immune responses. Molecular Therapy. 32(12). 4482–4496. 2 indexed citations
2.
Liu, Nan, Yuqi Yang, Yang Wang, et al.. (2024). Next-generation anti-PD-L1/IL-15 immunocytokine elicits superior antitumor immunity in cold tumors with minimal toxicity. Cell Reports Medicine. 5(5). 101531–101531. 15 indexed citations
3.
Liu, Nan, et al.. (2024). Advancements and challenges in immunocytokines: A new arsenal against cancer. Acta Pharmaceutica Sinica B. 14(11). 4649–4664. 12 indexed citations
4.
Zhu, Wen, Yang Wang, Hui Wang, et al.. (2023). Universal chimeric Fcγ receptor T cells with appropriate affinity for IgG1 antibody exhibit optimal antitumor efficacy. Acta Pharmaceutica Sinica B. 13(5). 2071–2085. 3 indexed citations
5.
Wang, Yang, Huanhuan Chen, Meiqi Zhao, et al.. (2023). Oxidation and reduction analysis of therapeutic recombinant human interleukin-15 by HPLC and LC-MS. Applied Microbiology and Biotechnology. 107(10). 3217–3227. 1 indexed citations
6.
Wang, Hui, Daijie Chen, & Huili Lu. (2022). Anti-bacterial monoclonal antibodies: next generation therapy against superbugs. Applied Microbiology and Biotechnology. 106(11). 3957–3972. 25 indexed citations
7.
Chen, Jie, Yueqing Xie, Hua Jiang, et al.. (2021). Characterization of a novel bispecific antibody targeting tissue factor-positive tumors with T cell engagement. Acta Pharmaceutica Sinica B. 12(4). 1928–1942. 18 indexed citations
8.
Gao, Fei, Hui Wang, Lu Lu, et al.. (2020). Protective effects of anti-alginate monoclonal antibody against Pseudomonas aeruginosa infection of HeLa cells. Microbial Pathogenesis. 145. 104240–104240. 5 indexed citations
9.
Li, Chaodong, Mei Ge, Daijie Chen, et al.. (2020). RPL21 siRNA Blocks Proliferation in Pancreatic Cancer Cells by Inhibiting DNA Replication and Inducing G1 Arrest and Apoptosis. Frontiers in Oncology. 10. 1730–1730. 19 indexed citations
10.
Yang, Hui, Jiaxian Wang, Jianwei Zhu, et al.. (2019). Feasible development of stable HEK293 clones by CRISPR/Cas9-mediated site-specific integration for biopharmaceuticals production. Biotechnology Letters. 41(8-9). 941–950. 12 indexed citations
11.
Luo, Han, Buyong Ma, Meiqi Zhao, et al.. (2019). Molecular dynamics based improvement of the solubilizing self-cleavable tag Zbasic-ΔI-CM application in the preparation of recombinant proteins in Escherichia coli. Biochemical and Biophysical Research Communications. 513(2). 412–418. 1 indexed citations
12.
Zhang, Lei, et al.. (2018). Intermolecular disulfide bonds between unpaired cysteines retard the C-terminal trans-cleavage of Npu DnaE. Enzyme and Microbial Technology. 118. 6–12. 7 indexed citations
13.
Wang, Jiaxian, Manyu Luo, Han Luo, et al.. (2018). Rapid development of stable transgene CHO cell lines by CRISPR/Cas9-mediated site-specific integration into C12orf35. Applied Microbiology and Biotechnology. 102(14). 6105–6117. 56 indexed citations
14.
Chen, Huanhuan, Yueqing Xie, Hua Jiang, et al.. (2017). Purification of inclusion bodies using PEG precipitation under denaturing conditions to produce recombinant therapeutic proteins from Escherichia coli. Applied Microbiology and Biotechnology. 101(13). 5267–5278. 9 indexed citations
15.
Zhao, Linjing, Hongbing Wu, Aihua Zhao, et al.. (2014). The in vivo and in vitro study of polysaccharides from a two-herb formula on ulcerative colitis and potential mechanism of action. Journal of Ethnopharmacology. 153(1). 151–159. 48 indexed citations
16.
Shen, Jiaqing, Rong Wan, Zhenyu Shen, et al.. (2012). Chemokine receptor CXCR3 is involved in the acute pancreatitis-associated lung injury. Biomedicine & Pharmacotherapy. 66(5). 390–396. 12 indexed citations
17.
Wu, Zhenqian, Xiaodong Han, Qi Zheng, et al.. (2011). Interleukin 1 receptor antagonist reduces lethality and intestinal toxicity of 5-Fluorouracil in a mouse mucositis model. Biomedicine & Pharmacotherapy. 65(5). 339–344. 21 indexed citations
18.
Xiang, Di, Yiping Guo, Jing Zhang, et al.. (2010). Interleukin-1 receptor antagonist attenuates cyclophosphamide-induced mucositis in a murine model. Cancer Chemotherapy and Pharmacology. 67(6). 1445–1453. 20 indexed citations
19.
Zhang, Zhonghui, Lijuan Du, Di Xiang, et al.. (2009). Expression and purification of bioactive high-purity human midkine in Escherichia coli. Journal of Zhejiang University SCIENCE B. 10(2). 79–86. 10 indexed citations
20.
Zhang, Jing, Di Xiang, Shunying Zhu, et al.. (2008). Interleukin 1 receptor antagonist inhibits normal hematopoiesis and reduces lethality and bone marrow toxicity of 5-fluouracil in mouse. Biomedicine & Pharmacotherapy. 63(7). 501–508. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Arvinder Kapur Breakdown of academic impact, for papers by Zahra Payandeh Breakdown of academic impact, for papers by Kevin Van der Jeught Breakdown of academic impact, for papers by Haixun Guo Breakdown of academic impact, for papers by Ana Sofía Carvalho Breakdown of academic impact, for papers by Masaru Koyama Breakdown of academic impact, for papers by Jung‐Tung Hung Breakdown of academic impact, for papers by Ursula Elsässer‐Beile Breakdown of academic impact, for papers by Latha Pathangey
Rankless by CCL
2026